Stocks · Health care · Pharmaceutical Preparations

Olema Pharmaceuticals, Inc.

OLMA Clue Score20
United States Fiscal year ends December CIK 0001750284 Results filed 10 Aug 2026

What the insiders did No buying or selling

By person

12 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Bain Capital Life Sciences Investors, LLC entity
10% owner
—
—
—
4,300,000
$50.37M
−42.7%
G. Walmsley Graham
Director
—
—
—
1,408,875
$16.50M
−49.9%
Cyrus Harmon
Director
—
—
—
819,798
$9.60M
−6.1%
David C. Myles
Ch. Discov. & Non-Clin Dev Off
—
—
—
687,607
$8.05M
−6.4%
Bvf Partners L P/Il entity
Director
—
—
—
347,970
$4.08M
−91.6%
Sean Bohen
President and CEO
—
—
—
237,650
$2.78M
+57.5%
Shane William Charles Kovacs
Ch. Operating & Financial Off.
—
—
—
139,727
$1.64M
−71.2%
Sasha Lu Austin
VP of Finance and Controller
—
—
—
16,188
$189.63K
+260.7%
Naseem Zojwalla
Chief Medical Officer
—
—
—
4,488
$52.57K
−95.3%
Ian T Clark
Director
—
—
—
0
$0.00
—
Andrew Rappaport
Director
—
—
—
0
$0.00
—
Shawnte Mitchell
Chief Legal Officer
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.